Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on Bukwang Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 08 Jan 2023 | Contera Pharma ApS Enters Phase I Clinical Trial Agreement with BDD Pharma Ltd for undisclosed drug (GDCT0500550) | Contract Service Agreement |
Contera Pharma ApS
|
BDD Pharma Ltd
|
| 16 Nov 2022 | Contera Pharma to Acquire Rights to SOL 707 from Solural Pharma | Asset Transaction |
Contera Pharma ApS
|
Solural Pharma ApS
|
| 20 Jan 2022 | ImmPACT Bio Raises USD111 Million in Series B Financing | Venture Financing |
Surveyor Capital Ltd
Foresite Capital Management LLC
Orbimed Advisors LLC
Novartis Venture Fund
venBio Partners LLC
RM Global Partners LLC
Decheng Capital LLC
Bukwang Pharmaceutical Co Ltd |
ImmPACT Bio USA Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer